Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
Recruiting
Observational Study
COVID-19 Pneumonia
Sepsis
SARS-CoV-2 Acute Respiratory Disease
Pneumonia
Multiorgan Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Osijek University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The research will be retrospective, and will include all patients who were admitted during 2020 and 2021 in the COVID-19 ICU of University Hospital Center Osijek due to pneumonia caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The association of chest x-ray infiltrate evolution with changes in laboratory inflammatory parameters and respiratory function parameters will b…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pneumonia caused by SARS-CoV-2 virus
* Admission to the ICU COVID-19 unit
Exclusion Criteria:
\- Patients with lung tumors or history of lung resection
Contacts